{
    "Trade/Device Name(s)": [
        "FIDIS CONNECTIVE 10"
    ],
    "Submitter Information": "Biomedical Diagnostics S.A (bmd)",
    "510(k) Number": "K053653",
    "Predicate Device Reference 510(k) Number(s)": [
        "K950031",
        "K944169",
        "K944168",
        "K042629",
        "K993589",
        "K944173",
        "K944172",
        "K944171",
        "K981237"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LLL",
        "LKJ",
        "LKO",
        "LKP",
        "LSW",
        "LJM",
        "MQA"
    ],
    "Summary Letter Date": "March 13, 2006",
    "Summary Letter Received Date": "February 28, 2006",
    "Submission Date": "February 17, 2006",
    "Regulation Number(s)": [
        "21CFR866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear antibody immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "double stranded DNA (dsDNA)",
        "SSA 60kDa",
        "SSA 52kDa",
        "SSB",
        "Sm",
        "Sm/RNP",
        "Scl70",
        "Jo-1",
        "Ribosomes",
        "Centromeres"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FIDIS flow cytometer",
        "XYP platform",
        "FIDIS analyzer",
        "SD pump",
        "MLX-BOOSTER software"
    ],
    "Method(s)/Technology(ies)": [
        "Microparticle immunoassay",
        "Fluorescent immunoassay",
        "Flow cytometry"
    ],
    "Methodologies": [
        "Multiplexed bead-based immunoassay",
        "Semi-quantitative fluorescence detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Analyzer",
        "Platform",
        "Software",
        "Control",
        "Calibrator",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for FIDIS CONNECTIVE 10 multiplex flow cytometric assay for simultaneous detection of ten autoantibody specificities in human serum.",
    "Indications for Use Summary": "Screening and detection of antinuclear antibodies associated with connective tissue diseases (SLE, Sjogren's syndrome, MCTD, scleroderma, dermatomyositis, CREST syndrome) in human serum, using a multiplex fluorescent immunoassay.",
    "fda_folder": "Immunology"
}